Cardlytics Inc (CDLX) - Total Liabilities

Latest as of March 2026: $267.91 Million USD

Based on the latest financial reports, Cardlytics Inc (CDLX) has total liabilities worth $267.91 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CDLX asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Cardlytics Inc - Total Liabilities Trend (2015–2025)

This chart illustrates how Cardlytics Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Cardlytics Inc (CDLX) total assets.

Cardlytics Inc Competitors by Total Liabilities

The table below lists competitors of Cardlytics Inc ranked by their total liabilities.

Company Country Total Liabilities
Cho Bi
KO:001550
Korea ₩82.97 Billion
CervoMed Inc.
NASDAQ:CRVO
USA $3.03 Million
dMY Squared Technology Group Inc
NYSE MKT:DMYY
USA $27.18 Million
SG Choongbang Co Ltd
KO:001380
Korea ₩44.00 Billion
Thirdeye Systems Ltd
TA:THES
Israel ILA31.28 Million
ContextVision AB
OL:CONTX
Norway Nkr35.12 Million
T Scientific Co.Ltd
KQ:057680
Korea ₩21.22 Billion
King River Resources Ltd
AU:KRR
Australia AU$1.46 Million

Liability Composition Analysis (2015–2025)

This chart breaks down Cardlytics Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Cardlytics Inc to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.17 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -66.93 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.02 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cardlytics Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cardlytics Inc (2015–2025)

The table below shows the annual total liabilities of Cardlytics Inc from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $292.15 Million -9.47%
2024-12-31 $322.72 Million -26.55%
2023-12-31 $439.35 Million -8.40%
2022-12-31 $479.63 Million -16.31%
2021-12-31 $573.10 Million +115.98%
2020-12-31 $265.35 Million +227.40%
2019-12-31 $81.05 Million -20.38%
2018-12-31 $101.79 Million -67.11%
2017-12-31 $309.44 Million +1.89%
2016-12-31 $303.69 Million +24.24%
2015-12-31 $244.45 Million --

About Cardlytics Inc

NASDAQ:CDLX USA Advertising Agencies
Market Cap
$225.81 Million
Market Cap Rank
#23111 Global
#5055 in USA
Share Price
$3.92
Change (1 day)
-3.69%
52-Week Range
$0.60 - $6.00
All Time High
$157.18
About

Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company provides Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-o… Read more